3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Lung Neoplasms
3
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
5
tislelizumab
2
spartalizumab
2
Trastuzumab
2
Psychiatric Rehabilitation
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Interleukin-12 Subunit p35
2
Erlotinib Hydrochloride
2
Biopsy
2
trastuzumab deruxtecan
1
tipifarnib
1
regorafenib
1
prexasertib
1
niraparib
1
fludarabine
1
enzalutamide
1
entinostat
1
abiraterone
1
Vorinostat
1
Thalidomide
1
Taxes
1
Surveys and Questionnaires
1
Specimen Handling
1
Ritonavir
1
Radiotherapy
1
Radionuclide Imaging
1
Quality of Life
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Radionuclide Imaging
×
Thoracic
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled